However, leptin therapy has been actively used in patients with lipodystrophy, a disorder characterized by fat loss, severe insulin resistance, and NAFLD and steatohepatitis (NASH) (Akinci et al., 2018). The gene discussed is LEP; the disease is metabolic dysfunction-associated steatohepatitis.